Opinion

Video

Case 3: Persistently Active Central Retinal Vein Occlusion

Author(s):

Lisa J. Faia, MD ,David R. Lally, MD

In the third case, moderator Lisa J. Faia, MD presents her case of persistently active central retinal vein occlusion (CRVO), explaining her approach to switching this treatment-resistant patient to a newer agent.

Related Videos
2 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
Related Content
©Anamarila - stock.adobe.com
December 27th 2024

Alert: Alcon voluntarily recalls Systane Ultra PF lot due to potential fungal contamination

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Foundation Fighting Blindness joins University of Colorado Anschutz Medical Campus and leading institutions receive funding to fast track whole eye transplantation program
December 4th 2024

Foundation Fighting Blindness joins University of Colorado Anschutz Medical Campus and leading institutions receive funding to fast track whole eye transplantation program

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Site Logo
September 26th 2024

Las complejidades en la adopción de una nueva tecnología

Alcon to acquire Belkin Vision in deal estimated at $335 million
May 13th 2024

Alcon to acquire Belkin Vision in deal estimated at $335 million

© 2025 MJH Life Sciences

All rights reserved.